Mirasol Center for Healing is a licensed substance use treatment provider in Jamaica Plain, MA, listed in the SAMHSA treatment directory. It offers hospital inpatient care with medical staff on site around the clock. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. The program treats co-occurring mental health conditions alongside addiction. The facility reports accepting MassHealth. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Buprenorphine used in TreatmentNaltrexone used in Treatment
Payment accepted
Federal, or any government funding for substance use treatment programsMedicareMedicaidFederal military insurance (e.g., TRICARE)Private health insuranceCash or self-paymentState-financed health insurance plan other than MedicaidSAMHSA funding/block grants
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyState department of healthHospital licensing authorityFederally Qualified Health Center
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
170 Morton Street, Suite 4-South, Jamaica Plain, MA 02130
Hospital inpatient/24-hour hospital inpatientHospital inpatient detoxificationHospital inpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
801 Massachusetts Avenue, 5th Floor, Suite 5-C, Roxbury, MA 02119
OutpatientOutpatient detoxificationOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
OutpatientOutpatient detoxificationOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsMedicare
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare